1. Prosonix Announce Agreement With Trimel Biopharma
(News/Latest)

Prosonix has announced that it has entered into a multi-product co-development and licensing agreement with Trimel Biopharma (a subsidiary of Trimel Biopharma Holdings -Barbados) in order to collaborate ...

2. Prosonix Announce Agreement With Trimel Biopharma
(News/Newsflash)

Prosonix has announced that it has entered into a multi-product co-development and licensing agreement with Trimel Biopharma (a subsidiary of Trimel Biopharma Holdings -Barbados) in order to collaborate ...

3. September 1-3, 2010: The Science of Medicines, Nottingham, UK
(events/events)

... industrial institutions, providing state of the art technologies and a platform for the development of new pharmaceutical talent. For further details please refer to: http://www.ukpharmsci.org/Default.asp ...

4. Prosonix Announce The Scale-Up Of UMAX technology
(News/Latest)

... practice, and now enables the development and optimization of a wide range of mono and combination inhalation therapies. Successfully demonstrated on over 30 generic and novel drug molecules and combinations, ...

5. Prosonix Announce The Scale-Up Of UMAX technology
(News/Newsflash)

... and now enables the development and optimization of a wide range of mono and combination inhalation therapies. Successfully demonstrated on over 30 generic and novel drug molecules and combinations, customer ...

6. November 3-4, 2010: Crystallization & Polymorphism, Florida
(events/events)

... Transition (UMAX). The conference will feature the chemical development issues of solid-state chemistry and in particular will focus on the reproducible production of organic crystals in the correct form ...

7. Prosonix Announce The Launch Of UMAX technology
(News/Latest)

... excipient free, highly performing, stable drug particles, that offer significant quantifiable advantages over current industry practice, and now enables the development and optimization of a wide range ...

8. Prosonix Announce The Launch Of UMAX technology
(News/Newsflash)

... excipient free, highly performing, stable drug particles, that offer significant quantifiable advantages over current industry practice, and now enables the development and optimization of a wide range ...

9. UMAX Pharmaceutical Particle Engineering
(technology/Technology)

... and many new chemical entities (NCEs) under development. UMAX also provides the platform for a novel particle engineering solution whereby a single droplet containing the two or more APIs in an exact ...

10. In-house Development Pipeline
(Pharmaceuticals/Pharmaceuticals)

Prosonix welcomes enquiries from all parties interested in licensing and co-development opportunities. Please contact David Hipkiss CEO or Christian Jones BDM or Contact us In-house development pipeline ...

11. Partnered Development Pipeline
(Pharmaceuticals/Pharmaceuticals)

Prosonix welcomes enquiries from all parties interested in licensing and co-development opportunities. Please contact David Hipkiss CEO or Christian Jones BDM or Contact us Partnered development pipeline ...

12. Product Pipeline - Making Better Medicines
(Pharmaceuticals/Pharmaceuticals)

... delivery for several novel therapeutic targets. Our innovative pipeline addresses the large and fast-growing market sectors of asthma and COPD, and combines our own leading particle engineering developments ...

13. Prosonix CEO David Hipkiss talks to CHEManager
(News/Latest)

... clients. To read more about David's view of this emerging niche market of pharmaceutical particle engineering and sonocrystallization, and the developments of the company within the current business climate ...

14. Prosonix Attains International Quality Approval
(News/Latest)

... external auditors SGS (UK) Ltd.   This covers Prosonix full range of activities from the Research and Development of ultrasonic particle engineering solutions for crystallisation and formulation ...

15. Prosonix sponsor APS Inhalation 2009
(News/Latest)

... world's leading experts in the science of drug inhalation - chemistry, pharmacy, pharmacology and biology - will present important case studies, perspectives and the latest developments in this fascinating ...

16. Prosonix at Major Crystallization Conference
(News/Latest)

... days, you will hear important case studies, meet and network with your peers, keep informed about the latest developments and be able to take valuable information back to inspire all your team. In ...

17. Meet Prosonix at Informex 2009
(News/Latest)

... applications development and more. Prosonix technologies are proven across scale to give quantifiable productivity and performance enhancements in the primary and secondary manufacture of API's, excipients ...

18. FDA Quality by Design
(Pharmaceuticals/Pharmaceuticals)

... (the ICH Q8 guidelines of 2004) the pharmaceutical industry to improved invention, development and commercialization of structured products using technologies that will result in superior product quality. ...

19. Pharmaceuticals
(Pharmaceuticals/Pharmaceuticals)

... and have the potential to transform inhalation and oral drug delivery. For further information on our pharmaceutical research and development please refer to: SAX | DISCUS | PRT |Sonocrystallization ...

20. Particle Engineering
(Pharmaceuticals/Pharmaceuticals)

... span all aspects of the pharmaceutical development pipeline from discovery through to process optimisation / manufacture and formulation / drug delivery. Our aim is to make better medicines by embracing ...